Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma

Paul Gerard Guy Richardson*, Bart Barlogie, James Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Teru Hideshima, Hugh Xiao, Dixie Esseltine, David Schenkein, Kenneth C. Anderson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Fingerprint Dive into the research topics of 'Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds